Humanwell Healthcare Group Co., Ltd. (600079)

Overview

Humanwell Healthcare (Group) Co., Ltd., is a prominent healthcare company engaged in the research, development, production, and international sale of pharmaceutical products. The company, which underwent a name change in March 2013 from Wuhan Humanwell Healthcare (Group) Co., Ltd. to its current designation, was established in 1993. Headquartered in Wuhan, China, Humanwell Healthcare has significantly impacted both local and global markets by providing a diverse range of pharmaceutical products and services aimed at addressing various medical needs and promoting overall health well-being.

Products and Services

• Sufentanil Citrate Injection: Used for endotracheal intubation, and general anesthesia with artificial respiration, marking its importance in surgical procedures.
• Remifentanil Hydrochloride Injection: This product is intended for the induction of general anesthesia, showcasing its critical role in preparing patients for surgery.
• Hydromorphone Hydrochloride Injection: Aimed at patients requiring opioid analgesia, it's a key component in pain management strategies.
• Nabuphine Hydrochloride Injection: Used for anesthesia induction, emphasizing its utility in facilitating smoother surgical procedures.
• Alfentanil Hydrochloride Injection: This product focuses on the general anesthesia induction, enhancing the range of options available for anesthesiologists.
• Mifepristone Preparations: Provides a clinical remedy for pregnancy termination or as preventive measures against pregnancy, indicating the company's involvement in reproductive health.
• Compound Muniziqi Granules: Used to regulate endocrine, enhance immune function, treat liver and gallbladder inflammation, skin diseases, and detoxify the body, underscoring the company's commitment to holistic health treatments.
• Urokinase Injection: Targeting thromboembolic disease, this product emphasizes Humanwell's involvement in critical care medications.
• Neomycin Sulfate API Related Preparations: Utilized for the prevention and treatment of intestinal diseases in animals and external prevention and treatment of human skin, eyes, nose, and ears infections, showcasing the company's dual focus on both veterinary and human medicines.
• Progesterone API Relevant Preparations: These are used for diagnosing and treating various conditions related to threatened abortion, habitual abortion, amenorrhea, highlighting the company’s contribution to women's health.
• Nervous System Drugs, Steroid Hormone Drugs, and Uighur Ethnic Medicines: A diverse range of medications addressing different health issues, indicating the breadth of Humanwell's pharmaceutical portfolio.
• Anti-Infection Drugs, OTC Medicines, and Other Products: This broad category includes medications aimed at treating infections, over-the-counter drugs, and other healthcare items, pointing to Humanwell's extensive reach in healthcare provisioning.